A Study to Evaluate the Efficacy, Safety and Immunogenicity of a Vaccine Designed to Protect Against Infection With Shigella Sonnei in Healthy Adults
Condition: Dysentery, Bacillary Interventions: Biological: GSK3536852A vaccine; Drug: GAHB-Placebo Sponsor: GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 17, 2018 Category: Research Source Type: clinical trials